FDA Inspection 1048450 — Shandong Analysis and Test Center
The FDA completed an inspection of Shandong Analysis and Test Center on March 26, 2018 in Jinan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 26, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)